Search company, investor...


Founded Year



Unattributed | Alive

Total Raised


Last Raised

$2.01M | 22 yrs ago



Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+10 points in the past 30 days

About RadNet

RadNet is a national provider of diagnostic imaging services in the United States. It offers a range of imaging services including digital and 3D mammography, X-ray, nuclear medicine, dual-energy X-ray absorptiometry (DEXA) for bone density measurement, and more. The company was founded in 1984 and is based in Los Angeles, California.

Headquarters Location

1510 Cotner Avenue

Los Angeles, California, 90025,

United States


Missing: RadNet's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: RadNet's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing RadNet

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned RadNet in 2 CB Insights research briefs, most recently on Dec 7, 2022.

Expert Collections containing RadNet

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RadNet is included in 3 Expert Collections, including Medical Devices.


Medical Devices

242 items

Medical Device New Products & Services Tech MM (August 2021)


Health Monitoring & Diagnostics

315 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging


Health IT

363 items

Latest RadNet News

Global Diagnostic Imaging Market is anticipated to reach US$ 49.29 Billion by 2028 growing with a CAGR of 5.82% from 2022 to 2028

Jan 18, 2023

Lyon, FRANCE New York, Jan. 18, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Diagnostic Imaging Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" - In addition, diagnostic imaging procedures like ultrasound, X-ray, MRI, etc., can visualize inside body organs so patients can access better care. Worldwide Diagnostic Imaging Market was US$ 35.11 Billion in 2022 The demand for point-of-care imaging systems and the surge in enhanced optical image demand for more accurate disease and disorder detection are the main reasons driving the expansion of the global diagnostic imaging market. Additionally, the rise in chronic disease prevalence and technological developments in medical imaging are anticipated to expand the market. Furthermore, the increased R&D in imaging technologies, growth in approved products, and growth of hospitals and diagnostic facilities, as well as government and private organization initiatives to enhance the medical sector, influence market trends for global diagnostic imaging. X-Ray is largely used in the Diagnostic Imaging Market By product, the X-ray segment dominated the global diagnostic imaging market. The surge in the usage of interventional x-ray equipment, such as C-arms and others, for image-guided surgeries, is the main factor driving this segment’s rise. Furthermore, the ultrasound segment will grow during the forecast period because of the surge in ultrasonic applications. Additionally, new applications for ultrasound devices in biomedical and cardiovascular imaging have been made possible by recent advancements in advanced ultrasound transducers. By Application: Orthopedic Segment holds a Lion’s Market Share The demand for the orthopedics market is increasing due to the rise in ageing population and an increase in accidents. Additionally, the availability of various diagnostic tools is promoting market expansion. Furthermore, the cardiovascular and oncology segment also holds a significant share due to the increased prevalence of cardiovascular and oncology diseases, rise in technological advancement, and better reimbursement policy. Hospital Segment Acquires the Majority of the Market Share Based on end-user, the global diagnostic market is divided into hospitals, diagnostic centers, and others. The primary driver of the hospital segment’s growth is the widespread adoption of public and private hospitals worldwide. In addition, rising investments in constructing technologically advanced hospitals equipped with modern diagnostic imaging technology will further contribute to the segment’s growth. Furthermore, Diagnostic Centers will upsurge during the forecast period due to the expansion of private imaging centers and the rising demand for diagnostic imaging procedures. North America dominates the Diagnostic Imaging Market North American region leads the global diagnostic imaging market. The main drivers of regional market expansion are the rise in the prevalence of chronic disease, the presence of numerous industry players, and the frequent introduction of new products in the region. Furthermore, due to favorable reimbursement scenarios and funding from market players, the North American region shows strong adoption of advanced and high-end medical imaging equipment. Additionally, the Asia Pacific region will grow during the forecast period due to expansion in hospitals, a surge in demand for early diagnosis, an increase in the prevalence of cancer and heart disease, and an increase in the geriatric population. Key Players Analysis: FUJIFILM VisualSonics Inc., Canon Medical Systems Corporation, Bruker, PerkinElmer Inc., Hitachi, Hologic, Radnet, and Koninklijke Philips are the leading market players in the Global Diagnostic Imaging Market. The numerous development strategies, such as introducing new products with various characteristics, promote market expansion and present profitable expansion prospects to the market participants. This latest report “Diagnostic Imaging Market Global Forecast by Product (X-Ray, CT, Ultrasound, MRI, Nuclear Imaging, Others), by Application (Orthopedics, Cardiovascular, Neurology, Pelvic & Abdomen, Oncology), by End User (Hospitals, Diagnostic Centres, Others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa), Key Players Analysis (FUJIFILM VisualSonics Inc., Canon Medical Systems Corporation, Bruker, PerkinElmer Inc., Hitachi, Hologic, Radnet and Koninklijke Philips)” provides a detailed analysis of Diagnostic Imaging Industry. Product – Global Diagnostic Imaging Market has been covered from 6 viewpoints 1. X-Ray

RadNet Frequently Asked Questions (FAQ)

  • When was RadNet founded?

    RadNet was founded in 1984.

  • Where is RadNet's headquarters?

    RadNet's headquarters is located at 1510 Cotner Avenue, Los Angeles.

  • What is RadNet's latest funding round?

    RadNet's latest funding round is Unattributed.

  • How much did RadNet raise?

    RadNet raised a total of $66.7M.

  • Who are the investors of RadNet?

    Investors of RadNet include Siemens, Battery Ventures, Evergreen Venture Partners and Gemini Israel Ventures.

  • Who are RadNet's competitors?

    Competitors of RadNet include Ibex Medical Analytics, Koios Medical, Cleerly, Lunit, Aidoc Medical,, SenseTime, Overjet, Aiforia, DiA Imaging Analysis and 24 more.

Compare RadNet to Competitors

PathAI Logo

PathAI provides AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. PathAI was founded in 2016 and is based in Boston, Massachusetts.

Ibex Medical Analytics Logo
Ibex Medical Analytics

Ibex Medical Analytics develops clinical decision support tools that help pathologists deliver metric-driven, objective and accurate diagnoses. It develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to help confirm cancer diagnoses of tissue biopsies. The company was founded in 2016 and is based in Tel Aviv, Israel.

Overjet Logo

Overjet offers a digital platform that uses AI technology to analyze dental patient data and provide diagnosis and treatment plan proposals.

Perspectum Logo

Perspectum develops digital healthcare technology designed to offer non-invasive alternatives to traditional abdominal testing methods. It focuses on the detection, and quantitative measurement of the liver, gall bladder, and pancreatic diseases to support diagnosis, treatment decision-making, and monitoring of the progression of it. The company was founded in 2012 and is based in Oxford, U.K.

RapidAI Logo

RapidAI is using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.

Cleerly Logo

Cleerly is a healthcare company that uses AI-powered imaging to analyze heart scans and whose mission is to create digital care pathways to prevent heart attacks. The company integrates clinical science with AI in order to offer clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, it aims to provide a comprehensive solution for cardiovascular disease evaluation that offers great value to the healthcare system and improves heart health for patients at risk of heart attacks. The company was founded in 2017 and is based in New York, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.